Deliberate Dysentery
Codon
JANUARY 21, 2024
The European Medicines Agency (EMA) is similar in this regard, although interestingly, that’s not the case in the United Kingdom, where regulators are not so directly involved in assessing a challenge study beforehand. There have been deaths in phase 1 medical and drug research among healthy participants. So that's a drawback.
110 
Let's personalize your content